Drug susceptibility testing of anaerobic protozoa

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 6, 2001, Pages 1810-1814

  Upcroft, Jacqueline A ^a,b   Upcroft, Peter ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG MONITORING; ENTAMOEBA HISTOLYTICA; GIARDIA DUODENALIS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; TRICHOMONAS VAGINALIS;

ALBENDAZOLE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIPROTOZOAL AGENTS; ENTAMOEBA; GIARDIA; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; TRICHOMONAS VAGINALIS;

EID: 0035010668     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.6.1810-1814.2001     Document Type: Article

References (46)

1. Boreham, P. F. L. 1991. Giardiasis and its control. Pharm. J. 234:271-274.
2. Boreham, P. F. L., R. E. Phillips, and R. W. Shepherd. 1984. The sensitivity of Giardia intestinalis to drugs in vitro. J. Antimicrob. Chemother. 14:449-461.
3. Boreham, P. F. L., R. E. Phillips, and R. W. Shepherd. 1988. Altered uptake of metronidazole in vitro by stocks of Giardai intestinalis with different drug sensitivities. Trans. R. Soc. Trop. Med. Hyg. 82:104-106.
4. Bowden, F. J., and G. P. Garnett. 1999. Why is Trichomonas vaginalis ignored? Sex. Transm. Infect. 75:372-373.
5. Brown, D. M., J. A. Upcroft, H. N. Dodd, N. Chen, and P. Upcroft. 1999. Alternative 2-keto acid oxidoreductase activities in Trichomonas vaginalis. Mol. Biochem. Parasitol. 98:203-214.
6. Burchard, G. D., and D. Mirelman. 1988. Entamoeba histolytica: virulence potential and sensitivity to metronidazole and emetine of four isolates possessing nonpathogenic zymodemes. Exp. Parasitol. 66:231-242.
7. Caballero-Salcedo, A., M. Viveros-Rogel, B. Salvatierra, R. Tapia-Conyer, J. Sepulveda-Amor, G. Gutierrez, and L. Ortiz-Ortiz. 1994. Seroepidemiology of amebiasis in Mexico. Am. J. Trop. Med. Hyg. 4:412-419.
8. Cohen, J. 2000. HIV transmission - AIDS researchers look to Africa for new insights. Science 287:942.
9. Cohen, M. S. 1998. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 351(Suppl. 3):5-7.
10. Diamond, L. S., D. Harow, and C. C. Cunnick. 1978. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans. R. Soc. Trop. Med. Hyg. 72:431-432.
11. Edlind, T. D., T. L. Hang, and P. R. Chakraborty. 1990. Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro. J. Infect. Dis. 162:1408-1411.
12. Farthing, M. J. G. 1993. Diarrhoeal disease: current concepts and future challenges. Pathogenesis of giardiasis. Trans. R. Soc. Trop. Med. Hyg. 87: 17-21.
13. Freeman, C. D., N. E. Klutman, and K. C. Lamp. 1997. Metronidazole. A therapeutic review and update. Drugs 54:679-708.
14. Gero, A. M., E. W. Kang, J. E. Harvey, P. J. Schofield, K. Clinch, and R. H. Furneaux. 2000. Trichomonas vaginalis: detection of nucleoside hydrolase activity as a potential screening procedure. Exp. Parasitol. 94:125-128.
15. Gillin, F. D. 1984. The role of reducing agents and the physiology of trophozoite attachment, p. 111-130. In S. L. Erlandsen and E. A. Meyer (ed.), Giardia and giardiasis. Plenum Press, New York, N.Y.
16. Hall, A., and Q. Nahar. 1993. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans. R. Soc. Trop. Med. Hyg. 87:84-86.
17. Hand, W. L. 2000. Current challenges in antibiotic resistance. Adolesc. Med. 11:427-438.
18. Kang, E. W., K. Clinch, R. H. Furneaux, J. E. Harvey, P. J. Schofield, and A. Gero. 1998. A novel and simple colorimetric method for screening Giardia intestinalis and anti-giardial activity in vitro. Parasitology 117:229-234.
19. Keister, D. B. 1983. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans. R. Soc. Trop. Med. Hyg. 77:487-488.
20. Kulda, J., J. Tachezy, and A. Erkasovová. 1993. In vitro induced anaerobic resistance to metronidazole in Trichomonas vaginalis. J. Eukaryot. Microbiol. 40:262-269.
21. Lau, A. H., N. P. Lam, S. C. Piscitelli, L. Wilkes, and L. H. Danziger. 1992. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives. Clin. Pharmacokinet. 23:328-364.
22. Lemée, V., I. Zaharia, G. Nevez, M. Rabodonirina, P. Brasseur, J. J. Ballet, and L. Favennec. 2000. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. J. Antimicrob. Chemother. 46:819-821.
23. Liu, S. M., D. M. Brown, P. O'Donoghue, P. Upcroft, and J. A. Upcroft. 2000. Ferredoxin involvement in metronidazole resistance of Giardia duodenalis. Mol. Biochem. Parasitol. 108:137-140.
24. Meri, T., T. S. Jokiranta, L. Suhonen, and S. Meri. 2000. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations. J. Clin. Microbiol. 38:763-767.
25. Monet, D. L. 2000. Toward multinational antimicrobial resistance surveillance systems in Europe. Int. J. Antimicrob. Agents 15:91-101.
26. Müller, M. 1990. Biochemistry of Trichomonas vaginalis, p. 53-83. In B. M. Honigberg (ed.), Trichomonads parasite in humans. Springer-Verlag, New York, N.Y.
27. Müller, M., and T. E. Gorrell. 1983. Metabolism and metronidazole uptake in Trichomonas vaginalis isolates with different metronidazole susceptibilities. Antimicrob. Agents Chemother. 24:667-673.
28. Rein, M. F., and M. Müller. 1990. Trichomonas vaginalis and trichomoniasis, p. 481-492. In K. K. Holmes, P.-A. Mårdh, P. F. Sparling, and P. J. Wiesner (ed.), Sexually transmitted diseases. McGraw-Hill Book Co., New York, N.Y.
29. Samarawickrema, N. A., D. M. Brown, J. A. Upcroft, N. Thammapalerd, and P. Upcroft. 1997. Involvement of superoxide dismutase and pyruvate: ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. J. Antimicrob. Chemother. 40:833-840.
30. Saurina, G. R., and W. M. McCormack. 1997. Trichomoniasis in pregnancy. Sex. Transm. Dis. 24:361-362.
31. Scully, B. E. 1988. Metronidazole. Med. Clin. North Am. 72:613-621.
32. Sobel, J. D., V. Nagappan, and P. Nyirjesy. 1999. Metronidazole-resistant vaginal trichomoniasis - an emerging problem. N. Engl. J. Med. 341:292-293.
33. Thammapalerd, N., S. Tharavanij, and Y. Wattanaoon. 1993. Axenic cultivation of Entamoeba histolytica from liver abscess and its zymodeme. Southeast Asian J. Trop. Med. Public Health 24:480-483.
34. Townson, S. M., H. Laqua, P. Upcroft, P. F. L. Boreham, and J. A. Upcroft. 1992. Induction of metronidazole and furazolidone resistance in Giardia. Trans. R. Soc. Trop. Med. Hyg. 86:521-522.
35. Townson, S. M., J. A. Upcroft, and P. Upcroft. 1996. Characterisation and purification of pyruvate: ferredoxin oxidoreductase from Giardia duodenalis. Mol. Biochem. Parasitol. 97:183-193.
36. Upcroft, J. A., R. W. Campbell, K. Benakli, P. Upcroft, and P. Vanelle. 1999. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas and Entamoeba spp. Antimicrob. Agents Chemother. 43:73-76.
37. Upcroft, J. A., R. Mitchell, N. Chen, and P. Upcroft. 1996. Albendazole resistance in Giardia is correlated with cytoskeletal but not with a mutation at amino acid 200 in β-tubulin. Microb. Drug Resist. 2:303-308.
38. Upcroft, J. A., P. F. L. Boreham, R. W. Campbell, R. W. Shepherd, and P. Upcroft. 1995. Biological and genetic analysis of a longitudinal collection of Giardia samples derived from humans. Acta Trop. 60:35-46.
39. Upcroft, J. A., and P. Upcroft. 1993. Drug resistance and Giardia. Parasitol. Today 9:187-190.
40. Upcroft, P., and J. A. Upcroft. 2001. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin. Microbiol. Rev. 14:150-164.
41. Viikki, M., E. Pukkala, P. Nieminen, and M. Hakama. 2000. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol. 39:71-75.
42. Voolmann, T., and P. F. L. Boreham. 1993. Metronidazole resistant Trichomonas vaginalis in Brisbane. Med. J. Aust. 159:490.
43. Wachter, D. A., M. P. Joshi, and B. Rimal. 1999. Antibiotic dispensing by drug retailers in Kathmand, Nepal. Trop. Med. Int. Health 4:782-788.
44. Warhurst, D. C. 1999. Drug resistance in Plasmodium falciparum malaria. Infection 27(Suppl. 2):S55-S58.
45. Wassmann, C., A. Hellberg, E. Tannich, and I. Bruchhaus. 1999. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J. Biol. Chem. 274:26051-26056.
46. Zalcberg, J., X. F. Hu, A. Slater, J. Parisot, S. El-Osta, P. Kantharidis, S. T. Chou, and J. D. Parkin. 2000. MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines. Prostate Cancer Prostatic Dis. 3:66-75.